Cargando…
High-dose intravenous hydromorphone for patients who use opioids in the hospital setting: time to reduce the barriers
Individuals who use opioids have higher rates of hospitalization compared to the general population. Insufficiently treated withdrawal and pain are major factors contributing to high rates of self-initiated hospital discharges (also referred to as leaving against medical advice) in this population....
Autores principales: | Labonté, Laura E., Young, Samantha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361239/ https://www.ncbi.nlm.nih.gov/pubmed/34389007 http://dx.doi.org/10.1186/s12954-021-00533-0 |
Ejemplares similares
-
Rifampin Reduces the Plasma Concentrations of Oral and Intravenous Hydromorphone in Healthy Volunteers
por: Lohela, Terhi J., et al.
Publicado: (2020) -
Prospective investigation of intravenous patient-controlled analgesia with hydromorphone or sufentanil: impact on mood, opioid adverse effects, and recovery
por: Yang, Yanqing, et al.
Publicado: (2018) -
Morphine versus Hydromorphone: Does Choice of Opioid Influence Outcomes?
por: Gulur, Padma, et al.
Publicado: (2015) -
Hydromorphone-Induced Tactile Hallucinations: Rare Opioid Side Effect
por: Kiyokawa, Miki, et al.
Publicado: (2021) -
Efficacy of opioid rotation to continuous parenteral hydromorphone in advanced cancer patients failing on other opioids
por: Oldenmenger, Wendy H., et al.
Publicado: (2011)